Money Concepts Capital Corp Reduces Stock Holdings in Humana Inc. (NYSE:HUM)

Money Concepts Capital Corp lowered its stake in Humana Inc. (NYSE:HUM) by 4.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,781 shares of the insurance provider’s stock after selling 121 shares during the period. Money Concepts Capital Corp’s holdings in Humana were worth $706,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. International Assets Investment Management LLC boosted its stake in shares of Humana by 261,025.1% during the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after purchasing an additional 738,701 shares in the last quarter. FMR LLC lifted its holdings in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares during the period. Thrivent Financial for Lutherans boosted its position in Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock valued at $190,145,000 after acquiring an additional 214,535 shares in the last quarter. Retirement Systems of Alabama grew its holdings in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares during the period. Finally, Pzena Investment Management LLC grew its holdings in shares of Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after acquiring an additional 187,903 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the topic of several research reports. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Wells Fargo & Company decreased their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Stephens reissued an “equal weight” rating and set a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Finally, Morgan Stanley raised their target price on shares of Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus target price of $297.68.

Humana Price Performance

HUM opened at $290.52 on Thursday. The company’s 50-day simple moving average is $275.13 and its two-hundred day simple moving average is $299.72. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market capitalization of $34.98 billion, a P/E ratio of 25.73, a P/E/G ratio of 2.21 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.29% of the stock is currently owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.